SeaTown Holdings’s iShares Biotechnology ETF IBB Stock Holding History

SeaTown Holdings’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-157,440	Closed	-$15.4M	–	52
2017 Q1	$15.4M	Buy	+157,440	New	+$15.1M	2.06%	21

Other funds holding IBB

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

SeaTown Holdings's IBB Position: Q2 2017 in Review

SeaTown Holdings sold out of iShares Biotechnology ETF (IBB) in Q2 2017, closing a stake of 157,440 shares — an estimated $15.4M sold.

SeaTown Holdings first reported a position in IBB in Q1 2017 and held it in 1 quarter. The position peaked at $15.4M in Q1 2017. 561 funds tracked by Wall St. Rank hold IBB as of Q2 2017.

SeaTown Holdings reported no remaining iShares Biotechnology ETF position as of Q2 2017 after selling out during the quarter.
SeaTown Holdings sold 157,440 iShares Biotechnology ETF shares in Q2 2017, an estimated $15.4M.
SeaTown Holdings first reported a position in iShares Biotechnology ETF in Q1 2017 and held it in 1 quarter.
SeaTown Holdings's iShares Biotechnology ETF position peaked at $15.4M in Q1 2017.
561 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2017.

Based on SeaTown Holdings's 13F filing for Q2 2017, filed 31 Jul 2017.